Search Results - "Yanover, Eva"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis by Wilting, Roel H, Yanover, Eva, Heideman, Marinus R, Jacobs, Heinz, Horner, James, van der Torre, Jaco, DePinho, Ronald A, Dannenberg, Jan-Hermen

    Published in The EMBO journal (04-08-2010)
    “…Histone deacetylases (HDACs) counterbalance acetylation of lysine residues, a protein modification involved in numerous biological processes. Here, Hdac1 and…”
    Get full text
    Journal Article
  2. 2

    Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis by Heideman, Marinus R, Lancini, Cesare, Proost, Natalie, Yanover, Eva, Jacobs, Heinz, Dannenberg, Jan-Hermen

    Published in Haematologica (Roma) (01-08-2014)
    “…Class I histone deacetylases are critical regulators of gene transcription by erasing lysine acetylation. Targeting histone deacetylases using relative…”
    Get full text
    Journal Article
  3. 3

    Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant in Prostate and Pancreatic Cancers by Oberg, Daniel, Yanover, Eva, Adam, Virginie, Sweeney, Katrina, Costas, Celina, Lemoine, Nick R, Halldén, Gunnel

    Published in Clinical cancer research (15-01-2010)
    “…Purpose: Replication-selective oncolytic adenoviruses are a promising class of tumor-targeting agents with proven safety in hundreds of patients. However,…”
    Get full text
    Journal Article
  4. 4

    Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function by Heideman, Marinus R., Wilting, Roel H., Yanover, Eva, Velds, Arno, de Jong, Johann, Kerkhoven, Ron M., Jacobs, Heinz, Wessels, Lodewyk F., Dannenberg, Jan-Hermen

    Published in Blood (14-03-2013)
    “…Histone deacetylases (HDACs) are epigenetic erasers of lysine-acetyl marks. Inhibition of HDACs using small molecule inhibitors (HDACi) is a potential strategy…”
    Get full text
    Journal Article